Patents for A61P 35 - Antineoplastic agents (221,099)
07/2006
07/05/2006EP1044005B1 1,2,4-benzotriazine oxides formulations
07/05/2006EP0923740B1 Methods and compositions for the detection of cervical cancer
07/05/2006EP0918514B9 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
07/05/2006EP0695360B1 Defective recombinant adenoviruses for gene therapy of tumours
07/05/2006CN1798975A Method of screening drug with the use of 67 KDA laminin receptor and drug obtained thereby
07/05/2006CN1798834A Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon
07/05/2006CN1798765A Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
07/05/2006CN1798749A Heteroryl-fused pyrimidinyl compounds as anticancer agents
07/05/2006CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren
07/05/2006CN1798739A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
07/05/2006CN1798561A Combined use of ecteinascidin-743 and platinum antineoplastic compounds
07/05/2006CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
07/05/2006CN1796557A Structure and application of antisense oligonucleotide with gene of mid-range factor as target
07/05/2006CN1796555A Small interference RNA molecule for restraining protein expression of DNA-PKCS, and encoding gene and application
07/05/2006CN1796418A Immune polysaccharide of rhizome of manyflower solomonseal, composition and application
07/05/2006CN1796414A New alpha - conantokins, coded polynucleotide and application
07/05/2006CN1796413A New T - ultra family conantokins, coded polynucleotide and application
07/05/2006CN1796411A New protein DDIP and coding genes and application
07/05/2006CN1796410A Function and application of MAAT1p15 antigen correlated to melanoma
07/05/2006CN1796401A Ramification of pentacycle triterpene, preparation method and application
07/05/2006CN1796400A Extractive of phytosterol extracted from bamboo shoot, preparation method and application
07/05/2006CN1796387A Benzo[b]pyrano[3,2-h]acridin-7-one cinnamate compounds, method of preparation and pharmaceutical composition thereof
07/05/2006CN1796382A A category of compound of new macrolide, preparation method and application
07/05/2006CN1796351A Method for preparing desmosdumotin, and application of anti tumour and AIDS
07/05/2006CN1795897A Chinese traditional medicine preparation for curing cancer of alimentary canal and ache in late cancer
07/05/2006CN1795877A Ganoderma lucidum capsule of lycopene
07/05/2006CN1795870A Medication composition of containing
07/05/2006CN1795867A Liposome of doxorubicin and prepration method and application
07/05/2006CN1795859A Alkaloid liposome in vinca and production technique
07/05/2006CN1795847A Liposome of Nitrocaphane and preparation method
07/05/2006CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
07/05/2006CN1262658C Recombined expression vector of restraining multiplication of leukemia cell
07/05/2006CN1262657C Method for producing human leukemia inhibitory factor using transgenic plant
07/05/2006CN1262636C Technology of producing high alcohol content nutritive wine using wolfberry and date as raw material
07/05/2006CN1262561C Synthetic poly peptide disturbing intracelluler signaling
07/05/2006CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation
07/05/2006CN1262542C Geldanamycin derivative and method of treating cancer same
07/05/2006CN1262541C Tricyclic protein kinase inhibitors
07/05/2006CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods
07/05/2006CN1262311C Medicinal composition for target direction transport curing cancer and its usage
07/05/2006CN1262309C Remedies for diseases in association with decreasing in bone mass
07/05/2006CN1262289C Application of antimonocytic activity of extracts of piper betel leaves
07/05/2006CN1262286C Method for extracting prostate cancer resisting active element from cole pollen
07/05/2006CN1262285C Liniment for skin and its preparation
07/05/2006CN1262275C Anticancer
07/04/2006US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents
07/04/2006US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides
07/04/2006US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
07/04/2006US7071337 Anticancer agents
07/04/2006US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors
07/04/2006US7071316 Human Akt-3
07/04/2006US7071300 IGF antagonist peptides
07/04/2006US7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
07/04/2006US7071221 Heterocyclic oxime compounds
07/04/2006US7071218 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
07/04/2006US7071217 Substituted oxindole derivatives as tyrosine kinase inhibitors
07/04/2006US7071216 Anticancer agents
07/04/2006US7071213 Cannabinoid receptor ligands
07/04/2006US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives
07/04/2006US7071207 Suppression appetite; induction weight loss
07/04/2006US7071203 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon
07/04/2006US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
07/04/2006US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases
07/04/2006US7071189 Heterocyclic compounds as antitumor agents with benzimidazole group and morpholine group, triazoline or pyrimidine heterocycles
07/04/2006US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction
07/04/2006US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation
07/04/2006US7071178 Bone disorders; osteoporosis
07/04/2006US7071165 LHRH antagonist peptides
07/04/2006US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes
07/04/2006US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions
07/04/2006US7071004 Isolated nucleic acids; uisng gene expression as indicator of cancer; insertion gene in transgenic animals
07/04/2006US7070977 Human serine protease D-G polypeptide
07/04/2006US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis
07/04/2006US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
07/04/2006US7070814 Plant extracts for treatment of cancer
07/04/2006US7070759 High dose radionuclide complexes for bone marrow suppression
07/04/2006US7070565 Solid hydrogel coupling for ultrasound imaging and therapy
07/04/2006CA2404848C Indole carboxylic acids as thyroid receptor ligands
07/04/2006CA2364719C 2-aminopyridines containing fused ring substituents
07/04/2006CA2332066C Tetrazole compounds as thyroid receptor ligands
06/2006
06/29/2006WO2006069395A2 Synthetic process for the preparation of biocyclic compounds
06/29/2006WO2006069208A2 Novel farnesyl protein transferase inhibitors as antitumor agents
06/29/2006WO2006069202A2 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies
06/29/2006WO2006069098A1 Nanoparticulate bicalutamide formulations
06/29/2006WO2006069096A1 Silanol derivatives as inhibitors of histone deacetylase
06/29/2006WO2006069063A1 Pyrrolidine inhibitors of iap
06/29/2006WO2006068975A2 Binding proteins specific for human matriptase
06/29/2006WO2006068769A1 Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
06/29/2006WO2006068760A2 Anti-inflammatory pyrazolopyrimidines
06/29/2006WO2006068410A1 Novel 3-(2-amino-6-pyridinyl)-4-hydroxyphenyl amine derivatives
06/29/2006WO2006068155A1 Agent for reconstructing neural network comprising chinese medicine formulation and method of reconstructing neural network
06/29/2006WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
06/29/2006WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
06/29/2006WO2006067614A2 Heteroaromatic derivatives useful as anticancer agents
06/29/2006WO2006067603A1 Therapeutic compounds isolated form calomeria amarnthoides
06/29/2006WO2006067498A1 Eicosapentaenoic acid for the treatment of cancer
06/29/2006WO2006067446A1 Pyridine carboxamide derivatives for use as anticancer agents
06/29/2006WO2006067401A1 Heterocyclic compounds as ccr2b antagonists
06/29/2006WO2006067391A1 Pyrazolylamino substituted quinazoles for the treatment of cancer
06/29/2006WO2006067311A2 Cdc25 phosphatase inhibitors